Mr James Davies

James Davies is the Lead PET-CT and MRI Technologist for the Mireille Gillings Neuroimaging Centre. 

He has a 10 year background in nuclear medicine diagnostics and therapies for the NHS performing a range of clinical duties including SPECT-CT, PET-CT, in-vitro, therapy, radiopharmacy and cell-labelling.  This was followed by 10 years in industry working for an imaging centre conducting research scans.  He worked across the PET-CT and MRI modalities contributing to study designs.  PET studies involved arterial blood sampling methodology, numerous niche tracers labelled with 18F or 11C, challenge agents and, at times, challenging study designs.  In MRI, James has contributed to numerous fMRI studies with a range of paradigms and external equipment, ASL, DTI, spectroscopy and all the other wonderful things MRI can do.  James was made the Lead PETMR Technologist upon the arrival of the new modality and conducted various neuro and non-neuro studies with simultaneous acquisitions and blood sampling.

James joined the university in 2024 and, at the Mireille Gillings Neuroimaging Centre, is the contact point for all study designs for PET-CT and MRI. He has currently set up several fMRI and MSK studies, managed C2P sequences and is developing a strong portfolio of commercial and academic work at the centre.  He is currently working on C13 spectroscopy and simultaneous fMRI-EEG.  James was also the lead technologist in the UK’s first multi-parametric PET-CT scans investigating Long-Covid and, for some reason, found himself injecting FDG into the leaf of a plant.